Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ursula Hille-Betz

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Deutsches Arzteblatt International|July 2, 2014
Consider family historySusanne Morlot, Bernd Auber, Ursula Hille-Betz, et al.
Women & Health|January 24, 2022
Clinical Differences between Invasive Lobular Breast Cancer and Invasive Carcinoma of No Special Type in the German Mammography-Screening-ProgramAndré Farrokh, Gloria Goldmann, Ulrike Meyer-Johann, et al.
Breast Care (Basel, Switzerland)|November 23, 2020
Quality of Life after Bilateral and Contralateral Prophylactic Mastectomy with Implant ReconstructionRüdiger Klapdor, Christina Weiß, Elna Kuehnle, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|September 30, 2015
Late radiation side effects, cosmetic outcomes and pain in breast cancer patients after breast-conserving surgery and three-dimensional conformal radiotherapy : Risk-modifying factorsUrsula Hille-Betz, Bernhard Vaske, Michael Bremer, et al.
International Journal of Breast Cancer|December 2, 2014
Dermoglandular rotation flaps for breast-conserving therapy: aesthetic results, patient satisfaction, and morbidity in comparison to standard segmentectomyUrsula Hille-Betz, Bernhard Vaske, Helga Henseler, et al.
Genes & Cancer|April 25, 2017
<i>GT198 (PSMC3IP)</i> germline variants in early-onset breast cancer patients from hereditary breast and ovarian cancer familiesStephanie Schubert, Tim Ripperger, Melanie Rood, et al.
Oncotarget|October 6, 2017
Functional dissection of breast cancer risk-associated <i>TERT</i> promoter variantsSonja Helbig, Leesa Wockner, Annick Bouendeu, et al.
Breast Cancer Research : BCR|August 9, 2018
Breast cancer patients suggestive of Li-Fraumeni syndrome: mutational spectrum, candidate genes, and unexplained heredityJudith Penkert, Gunnar Schmidt, Winfried Hofmann, et al.
Frontiers in Oncology|April 26, 2021
Plasma Metabolome Signature Indicative of <i>BRCA1</i> Germline Status Independent of Cancer IncidenceJudith Penkert, Andre Märtens, Martin Seifert, et al.
International Journal of Cancer|November 15, 2018
The identification of pathogenic variants in BRCA1/2 negative, high risk, hereditary breast and/or ovarian cancer patients: High frequency of FANCM pathogenic variantsStephanie Schubert, Jana L van Luttikhuizen, Bernd Auber, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Deutsches Arzteblatt International|July 2, 2014
Consider family historySusanne Morlot, Bernd Auber, Ursula Hille-Betz, et al.
Women & Health|January 24, 2022
Clinical Differences between Invasive Lobular Breast Cancer and Invasive Carcinoma of No Special Type in the German Mammography-Screening-ProgramAndré Farrokh, Gloria Goldmann, Ulrike Meyer-Johann, et al.
Breast Care (Basel, Switzerland)|November 23, 2020
Quality of Life after Bilateral and Contralateral Prophylactic Mastectomy with Implant ReconstructionRüdiger Klapdor, Christina Weiß, Elna Kuehnle, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|September 30, 2015
Late radiation side effects, cosmetic outcomes and pain in breast cancer patients after breast-conserving surgery and three-dimensional conformal radiotherapy : Risk-modifying factorsUrsula Hille-Betz, Bernhard Vaske, Michael Bremer, et al.
International Journal of Breast Cancer|December 2, 2014
Dermoglandular rotation flaps for breast-conserving therapy: aesthetic results, patient satisfaction, and morbidity in comparison to standard segmentectomyUrsula Hille-Betz, Bernhard Vaske, Helga Henseler, et al.
Genes & Cancer|April 25, 2017
<i>GT198 (PSMC3IP)</i> germline variants in early-onset breast cancer patients from hereditary breast and ovarian cancer familiesStephanie Schubert, Tim Ripperger, Melanie Rood, et al.
Oncotarget|October 6, 2017
Functional dissection of breast cancer risk-associated <i>TERT</i> promoter variantsSonja Helbig, Leesa Wockner, Annick Bouendeu, et al.
Breast Cancer Research : BCR|August 9, 2018
Breast cancer patients suggestive of Li-Fraumeni syndrome: mutational spectrum, candidate genes, and unexplained heredityJudith Penkert, Gunnar Schmidt, Winfried Hofmann, et al.
Frontiers in Oncology|April 26, 2021
Plasma Metabolome Signature Indicative of <i>BRCA1</i> Germline Status Independent of Cancer IncidenceJudith Penkert, Andre Märtens, Martin Seifert, et al.
International Journal of Cancer|November 15, 2018
The identification of pathogenic variants in BRCA1/2 negative, high risk, hereditary breast and/or ovarian cancer patients: High frequency of FANCM pathogenic variantsStephanie Schubert, Jana L van Luttikhuizen, Bernd Auber, et al.
Pageof 1